Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Aromatase Inhibitor-Associated Musculoskeletal Symptoms
NCT01509079Phase 2Completed
- Sponsor
- HealthPartners Institute
- Start
- Mar 2012
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS), sponsored by HealthPartners Institute. Started Mar 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS)
Beyond the preview
Go deeper on NCT01509079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01509079.